We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Mutant Spike Proteins and Antigens for SARS-CoV-2 Variant Research

Product News   Feb 17, 2021

 
Mutant Spike Proteins and Antigens for SARS-CoV-2 Variant Research

Credit: amsbio

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Product News

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.

READ MORE

Adaptate Biotherapeutics Raises $18 million in Series A2 Funding

Product News

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

READ MORE

AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform

Product News

AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE